Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT05667246
Status
Enrolling By Invitation

Conditions

  • Terbinafine Adverse Reaction

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Caffeinated Coffee — OTHER
    Subjects would be randomized to a group "Caffeinated" and subjects will be 95 mg of caffeine in caffeinated coffee.
  • Decaffeinated Coffee — OTHER
    Subjects would be randomized to a group "Decaffeinated" and subjects will be no caffeine in decaffeinated coffee.

Study Details

The investigators hypothesize that there would be significant changes in blood pressure or heart rate in patients consuming caffeine while taking terbinafine.

Key Dates

Start date
Jul 25, 2024
Status verified
Sep 2025
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
52 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Active Comparator: Caffeinated Group
    Caffeinated coffee, 1 cup, 8 oz water setting, 95 mg caffeine
  • Placebo Comparator: Decaffeinated Group
    Decaffeinated coffee, 1 cup, 8 oz water setting

Primary Outcome Measure

Change in Blood Pressure [ Time Frame: Baseline, 30 min after consuming caffeine, 60 minutes after consuming caffeine ]

Locations (1)

FacilityCityStateZIPSite coordinators
Weill Cornell MedicineNew YorkNew York10021-

Find similar trials in New York, NY

By research site
Weill Cornell Medicine· New York, NY